BIO International Conference

Eradicating disease seems like an elusive pipe dream but not if you ask Donna Cryer , president and CEO of the Global Liver Institute. “9,000 days ago, doctors told me I had seven days to live,” said Cryer. “I believe in our ability to continually adapt and innovate and conquer disease”. Cryer was joined by Research!America board member Dr. William Hait, global head, Janssen Research and Development, and fellow board member Dr. Mark McClellan, director, Duke-Robert J. Margolis Center for Health Policy, Duke University for an interactive panel discussion titled, A World Without Disease: Can We Get There? , at the BIO International Conference in San Diego, California on June 20. Research!...
Image credit: National Institutes of Health Technological advances have paved the way for researchers to access a wealth of data about the biological cause of disease. Yet translating these discoveries into treatments remains a challenge. Promising drugs often fail in late phase clinical trials, costing time and money, and leaving patients’€™ lives hanging in the balance. One reason is that the right biological targets were not chosen from the start. To improve the current model for developing new diagnostics and treatments, the National Institutes of Health (NIH) and several biopharmaceutical companies and non-profit organizations formed the Accelerating Medicines Partnership (AMP), www...
From KIYATEC website Matthew Gevaert and David Orr developed an innovative approach to cancer research, testing new drug compounds using live cells from patients with a device that resembles a Lego. Gevaert and Orr’€™s ’€œ3DKUBE,’€ a cell cultured plasticware, creates a 3Dmodel of patient cells that allows researchers to study the growth of the cells in a cultured environment that mimics the conditions of the human body. The process is designed to produce more relevant data on drug safety and efficacy, and determine which drugs are most effective for treating cancer patients. To expand use of this technology, the National Cancer Institute (NCI) awarded a $295,000 Phase 1 Small Business...

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter